We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Panel: In Abandoning Product, Appellant Lost Standing In Patent Appeal

Mealey's (February 8, 2019, 2:25 PM EST) -- WASHINGTON, D.C. — Momenta Pharmaceuticals Inc. forfeited any legally protected interest in the validity of a Bristol-Myers Squibb Co. (BMS) patent when it abandoned development of a proposed biosimilar drug, the...
To view the full article, register now.